Gemelli Biotech Launches Novel Breath Test
The company notes trio-smart™ is a Laboratory Developed Test (LDT) conducted at a CLIA-certified lab.
October 27, 2020
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news including new biotech developments, pharmaceuticals and more.
TAE Life Sciences and CNAO Announce a Research and Clinical Collaboration for the Implementation of a New Facility with Boron Neutron Capture Therapy System in Italy
TAE Life Sciences notes BNCT research has demonstrated compelling results for some of the most difficult to treat cancers, including recurrent head and neck, glioblastomas and melanoma.
October 27, 2020
Sakura Finetek Europe Announces the Launch of Tissue-Tek SmartConnect® – Enables a fully Automated Continuous Flow by Connecting, Processing and Embedding in the Histology Lab
This new innovative SMART solution enables a laboratory to optimize their workflow and work more efficient, eliminating repetitive and unnecessary manual work. Hence laboratory technicians can focus more on what matters most: taking care of the best possible patient journey.
October 21, 2020
UNION Therapeutics Announces Expansion of Clinical Pipeline: Adds UNI91103 to Prevent COVID-19 and Reduce the Severity of the Diseases Among Those Already Infected
Introduces UNI91103 (intranasal niclosamide) to prevent COVID-19 and reduce the severity of the diseases among those already infected.
October 21, 2020
XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure Using PASylation® Technology
Brian Johnson, Antlia Bioscience’s CEO commented, “chronic heart failure is a significantly unaddressed medical condition and a major public health concern. XL-protein’s PASylation® technology will allow us to safely and effectively translate our peptide into a meaningful therapeutic option for patients with chronic heart failure.
October 15, 2020
OpenEye Scientific Reports: Gigadocking™ in Orion™ Molecular Design Platform Rapidly Identifies Novel Chemical Entities for GPCR Targets
OpenEye Scientific notes to quickly identify novel active compounds for known GPCR targets in Orion, the Beacon Discovery team used structure-based virtual screening through OpenEye’s Gigadocking functionality—which performs massively parallel molecular docking through tens of thousands of CPUs at Amazon Web Service—and ligand-based virtual screening through FastROCS to rapidly screen the Enamine REAL collection of 2.5Bn commercially available molecules.
October 15, 2020
